The assisted living facility and neurorehabilitation market has seen considerable growth due to a variety of factors.
• The assisted living facility and neurorehabilitation market has grown significantly in recent years. It is projected to rise from $47.63 billion in 2024 to $51.55 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.2%.
This expansion is driven by the increasing demands of the aging population, a growing need for neurorehabilitation centers, the popularity of continuing-care retirement communities, and a rise in the number of traumatic brain injury survivors.
The assisted living facility and neurorehabilitation market is expected to maintain its strong growth trajectory in upcoming years.
• The assisted living facility and neurorehabilitation market is expected to grow significantly, reaching $69.74 billion by 2029, with a CAGR of 7.8%.
This growth is driven by the increasing demand for neurorehabilitation devices, the rising prevalence of neurological disorders, growing income among the senior population, and the preference for senior housing communities offering better healthcare. Trends in the forecast period include advancements in medicine and technology, adoption of robotic devices, and rapid uptake of new treatments.
The increasing demand for personalized senior care services is expected to drive the growth of the assisted living facility and neurorehabilitation market. As the elderly population grows, the demand for high-quality, personalized care is on the rise. Assisted living facilities that integrate neurorehabilitation services provide comprehensive support, combining daily living assistance with specialized therapeutic care. In 2021–22, government spending on aged care in Australia reached $24.8 billion, and it is projected to rise further due to the aging population. This demand for personalized care will continue to drive the growth of this market.
The assisted living facility and neurorehabilitation market covered in this report is segmented –
1) By Type: Women, Men
2) By Age: Less Than 65, 65-74, 75-84, More Than 85
3) By Application: Hospitals, Clinics, Personal Care, Other Applications
Subsegments:
1) By Women: Elderly Women, Women With Cognitive Disorders, Women With Physical Disabilities
2) By Men: Elderly Men, Men With Cognitive Disorders, Men With Physical Disabilities
Companies in the assisted living facilities and neurorehabilitation market are advancing technology with smart peripheral devices to gain a competitive edge. These devices are hyper-sensitive controllers that detect fine grasp forces and wrist movements for daily activities, aiding treatment for severely impaired patients. For example, in February 2023, MindMaze, a Switzerland-based digital therapeutics company, launched Izar, a smart peripheral device listed by the FDA and CE-marked for patients with impaired hand motor function. Izar aims to improve hand dexterity and strength in patients with conditions such as stroke, Parkinson's, Alzheimer's, and traumatic brain injury.
Major companies operating in the assisted living facility and neurorehabilitation market are:
• Community Health Systems Inc.
• Sevita Health
• Encompass Health Corporation
• Kindred Healthcare LLC
• Brookdale Senior Living
• Atria Senior Living Inc.
• SCA Health
• Belmont VillAge L.P.
• Aegis Living
• Craig Hospital
• NeuroRestorative
• Centre For Neuro Skills
• Bioness Inc.
• Texas NeuroRehab Center
• Catholic Eldercare
• Moody Neurorehabilitation Institute
• ResCare Inc.
• Sukino Healthcare Solutions Pvt. Ltd.
• TeamHealth
• Mary Lee Foundation
• Sanctus Rehabilitation Care Foundation
North America was the largest region in the assisted living facility and neurorehabilitation market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the assisted living facility and neurorehabilitation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.